(IDYA) Ideaya Biosciences - Performance -38.9% in 12m
IDYA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
14.90%
#25 in Peer-Group
Rel. Strength
12.42%
#6723 in Stock-Universe
Total Return 12m
-38.91%
#116 in Peer-Group
Total Return 5y
60.90%
#20 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 4.65 |
| High / Low | USD |
|---|---|
| 52 Week High | 43.05 USD |
| 52 Week Low | 14.50 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 89.49 |
| Buy/Sell Signal +-5 | 0.70 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IDYA (-38.9%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: IDYA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IDYA
| Total Return (including Dividends) | IDYA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.75% | 3.64% | 4.08% |
| 3 Months | 44.58% | 23.43% | 19.65% |
| 12 Months | -38.91% | -7.41% | 12.88% |
| 5 Years | 60.90% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | IDYA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -16.5% | 30.3% | 86.9% |
| 3 Months | 83.5% | 79.4% | 97.2% |
| 12 Months | -89.4% | -87.3% | 46% |
| 5 Years | 55.4% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th52.50 | -2.79% | -3.20% |
| 3 Month | %th69.00 | 17.13% | 20.83% |
| 12 Month | %th43.00 | -34.02% | -45.88% |
| 5 Years | %th91.00 | 103.00% | -24.63% |
FAQs
Does Ideaya Biosciences (IDYA) outperform the market?
No,
over the last 12 months IDYA made -38.91%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months IDYA made 44.58%, while XBI made 23.43%.
Performance Comparison IDYA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IDYA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.1% | -3.3% | -13.6% | -52% |
| US NASDAQ 100 | QQQ | 3.3% | -3.3% | -14.9% | -50% |
| German DAX 40 | DAX | 1% | -1.1% | -25.6% | -71% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.7% | -4.5% | -17.9% | -60% |
| Hongkong Hang Seng | HSI | 4.3% | -1.7% | -33.8% | -76% |
| India NIFTY 50 | INDA | 4.1% | 0.7% | -13.1% | -37% |
| Brasil Bovespa | EWZ | 8.6% | -1.1% | -29.6% | -41% |
IDYA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.4% | -1.4% | -17.1% | -62% |
| Consumer Discretionary | XLY | 3.1% | -1.8% | -5.9% | -56% |
| Consumer Staples | XLP | 4.5% | 0.9% | -12.7% | -46% |
| Energy | XLE | 1.2% | -4.4% | -7.1% | -41% |
| Financial | XLF | 4.1% | -2.8% | -17.3% | -67% |
| Health Care | XLV | 2.6% | -0.2% | -3.6% | -34% |
| Industrial | XLI | 2.3% | -4.1% | -20.6% | -64% |
| Materials | XLB | 2.2% | -3.6% | -17% | -45% |
| Real Estate | XLRE | 3.6% | 1.3% | -13% | -50% |
| Technology | XLK | 3.2% | -6.1% | -17.8% | -48% |
| Utilities | XLU | 2.3% | -2.1% | -15.9% | -61% |
| Aerospace & Defense | XAR | 2.8% | -5.8% | -31.7% | -88% |
| Biotech | XBI | -0.5% | -2.9% | -4% | -32% |
| Homebuilder | XHB | -0.2% | -7.6% | -9.2% | -45% |
| Retail | XRT | 2.8% | -2% | -8.1% | -50% |
IDYA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.9% | -4.54% | 1.39% | -33% |
| Natural Gas | UNG | 6.5% | 8.9% | 14.8% | -34% |
| Gold | GLD | 3.5% | 0.9% | -28.5% | -79% |
| Silver | SLV | 2.5% | -0.8% | -27.4% | -59% |
| Copper | CPER | -5.9% | -12.6% | -34.5% | -62% |
IDYA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.2% | -0.9% | -9.1% | -37% |
| iShares High Yield Corp. Bond | HYG | 3.5% | -0.5% | -10.1% | -49% |